Dr. Pierre Chue is Clinical Professor in the Department of Psychiatry at the University of Alberta, Departmental Head for Addictions and Mental Health, Alberta Health Services, and Consulting Psychiatrist with Telemental Health Services in the Province of Alberta. He describes his career as a medical researcher. He explains what is meant by “injectables”, “long-acting injectables”, and “antipsychotics”, and how these are used for medical treatment of schizophrenia. He explains the ways long-acting injectable antipsychotics address the challenges created by schizophrenia for individuals who live with it and for their families and family caregivers, and for the medical treatment of schizophrenia. He identifies challenges that persist. He highlights current research that addresses the main persistent challenges. He says what more he would like to do and see done to promote understanding of the value of long-acting injectable antipsychotics in the medical treatment of schizophrenia.